James E. Flynn - 10%+ Owner at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

James E. Flynn - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by James E. Flynn for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 5.26M $93.4M $17.77 Nov 12, 2024 Through Deerfield Private Design Fund III, L.P.
Class A Common Stock 5.26M $93.4M $17.77 Nov 12, 2024 Through Deerfield Private Design Fund IV, L.P.

Transactions reported by James E. Flynn for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.